Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 5, 2017
Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trialsRyan T Jones, Nima Hassan Rezaeian, Neil B Desai, et al.
Practical Radiation Oncology|December 12, 2022
Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic FossaHoward E Morgan, Kai Wang, Yulong Yan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2026
Stereotactic Ablative Radiotherapy for Oligoprogressive Metastatic RCC: Predictors of Prolonged Systemic Therapy BenefitLucian Zhao, Dana Keilty, Soumyajit Roy, et al.
International Journal of Radiation Oncology, Biology, Physics|February 7, 2021
Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 TrialVitaly Margulis, Yuval Freifeld, Laurentiu M Pop, et al.
Biomedicines|June 24, 2022
Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate CancerRaquibul Hannan, Michael J Dohopolski, Laurentiu M Pop, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2021
A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal SpacerMichael R Folkert, Michael J Zelefsky, Raquibul Hannan, et al.
Frontiers in Oncology|March 10, 2022
Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate CancerLily Chen, Bhavani S Gannavarapu, Neil B Desai, et al.
European Urology Oncology|August 19, 2022
Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney CancerRaquibul Hannan, Michael Christensen, Alana Christie, et al.
BJU International|June 6, 2017
Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution studyVasu Tumati, William C Jackson, Ahmed E Abugharib, et al.
European Urology|March 10, 2023
Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal CancerRaquibul Hannan, Mark F McLaughlin, Laurentiu M Pop, et al.
Pageof 11